/other/Diamyd_Medical_AB_publ-logo.png?Expires=1750138717&Signature=MRDn2b7XqHeGLKIND5TrfC13rjPPNCmztpwftr-sGi8~GU4UAe9C2Xc0Dnk2rBSAfybJl0X0qMRYv~pdeh6pXI8oBJ7CHrBa8XztUD8I8Zr52nYsMRz9xJUsYKALCNk3Uu8kPua-X3ni3JFdRUldmD5E8t-DhF7lVn9jSz9OISA3WizhHAz7JxiMQj6tgeYdTeZk6P1PK6ppm1Mk6NDUI9cx-hPpEvi5HH1wd2oNUEFIcI8eZXG~ZpZsaKxRqSW2SQaIrAS7FBzAvYkwBpkJJeQLpqkXlk1nFFlxTyKCuoUjq5AgL~uqeraDOtZRDeWN9l6OiiLgAQuAE2hQaFQOow__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Toleranzia AB | Sweden | TOL | |
|
Transgene | France | TNG | |
|
Tvardi Therapeutics Inc. | United States of America | TVRD | |
|
Ulisse Biomed | Italy | UBM | |
|
Univo Pharmaceuticals Ltd. | Israel | UNVO-M | |
|
Urteste S.A. | Poland | URT | |
|
Valbiotis | France | ALVAL | |
|
VALIRX PLC | United Kingdom | VAL | |
|
Vaxxa AB | Sweden | VAXXA | |
| Vision Sigma Ltd. | Israel | VISN |